Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

NCT01470612 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01470612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01470612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2012
Completion date
August 6, 2020
Enrollment
944 (actual)
Sites
252

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis